Top Markets
#1 0G 0G +43.84%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.97%
#3 StonkBroker StonkBroker +36.22%
#4 Useless Coin Useless Coin +33.99%
#5 SAFEcoin SAFEcoin +29.98%
#6 Zora Zora +27.85%
#7 Dogs Dogs +23.81%
#8 rsERG rsERG +23.50%
#9 Notcoin Notcoin +18.46%
#10 Huma Finance Huma Finance +16.49%
Coin of the day
0G 0G
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Impact Therap-b Impact Therap-b

Impact Therap-b

7630
Classificação em ações #13194
IMPACT Therapeutics, a biotechnology firm, specializes in the discovery and... IMPACT Therapeutics, a biotechnology firm, specializes in the discovery and advancement of precision anti-cancer treatments rooted in synthetic lethality, operating across China and international markets. The company's primary offering, Senaparib (IMP4297), is a PARP1/2 inhibitor currently deployed as a first-line maintenance therapy for ovarian cancer. Beyond this, Impact Therapeutics maintains a robust pipeline of investigational drugs. This includes IMP1734, a next-generation PARP1 selective inhibitor undergoing Phase I/II trials as a standalone treatment for advanced solid tumors. Another promising candidate is IMP9064, an ATR kinase selective inhibitor, also in Phase I/II clinical studies for advanced solid tumors as a monotherapy. IMP1707, a PARP1 selective inhibitor capable of penetrating the central nervous system, is in Phase I development for homologous recombination repair-deficient tumors. Additionally, IMP7068, an advanced WEE1 inhibitor, is progressing through Phase I/II clinical trials for various advanced solid tumors. Furthermore, a range of other compounds, namely IMP22, IMP25, IMP08, IMP13, IMP10, IMP27, and IMP32, are in the preclinical development phase. The company, established in 2009, is headquartered in Shanghai, China.
Preço da ação
$1.85
Valor de mercado
$510.85M
Variação (1 dia)
-7.37%
Variação (1 ano)
-
País
CN
Negociar Impact Therap-b (7630)

Categoria

Healthcare
Histórico de dividendos de Impact Therap-b (7630)
Impact Therap-b (símbolo da ação: 7630) realizou um total de 0 pagamentos de dividendos.
A soma de todos os dividendos (ajustada para desdobramentos de ações) é: 0.00
Rendimento de dividendos (TTM): 0
Pagamentos de dividendos de Impact Therap-b (7630) de 2026 a 2026
Pagamentos anuais de dividendos
Ano Dividendo (ajustado para desdobramentos) Alterar
Não há dados suficientes para as datas fornecidas.
Lista de todos os pagamentos de dividendos
Ano Dividendo Alterar
Não há dados suficientes para as datas fornecidas.
Dividendos de empresas semelhantes ou concorrentes
Empresa Número de pagamentos de dividendos País
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
215.00%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
225.00%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
53.00%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
33.00%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
223.00%
US